Cytokines and apoptosis genes polymorphisms influence the outcome of hepatitis C virus infection
© Ksiaa-Cheikh et al; licensee BioMed Central Ltd. 2010
Published: 25 November 2010
Chronic hepatitis C virus (HCV) infection persists despite the presence of specific humoral and cellular immune [1,2] responses and the factors leading to viral clearance or persistence are poorly understood [3-6].
To investigate the possibility of a significant relationship between outcome of HCV infection and cytokines/apoptosis genes polymorphisms.
Materials and methods
The polymorphisms of genes: IL-1 (-889 IL-1α, -511 and +3954 IL-1β, IL-1-Ra), IL-18 (-137 and -607), IL-12p40 (-1188) and Apo1/Fas (-670) were determined by PCR-RFLP, PCR-SSP and PCR-VNTR; in 100 Tunisian hemodialysed patients infected by the HCV and 100 healthy blood donors. The patients were classified in two groups: G1 included 76 active chronic hepatitis patients (positive RNA-HCV) and G2: 24 hemodialysed having eliminated spontaneously virus (negative RNA-HCV).
The univariate analyze of the genotypes and alleles frequencies of the cytokines polymorphisms studied do not reveal any positive or negative association statistically significant with the outcome of the HCV infection. Nevertheless, the frequency of genotype association [-37GC/-607CA] IL-18 is statistically higher among G2 patients (41,7%) compared to that at G1 hemodialysed (15,8%) (p=0,008, OR: 0.26, 95%CI: [0.10-0.73]). We found also, a significant increased frequency of AA genotype of Apo1/Fas gene in G2 patients (41,6%) than in G1 (17,5%) (p=0,026, OR=3,49, 95% CI [1,13-10,69]). Adjustment for known covariates factors (age, gender and genotypes) confirmed these univariate findings and revealed that the genotype association GC-CA of (-137and-607) IL-18 gene and AA genotype of Apo1/Fas gene were associated to the clearance of HCV (p=0.041 and p=0.017 respectively).
In Tunisian hemodialysed patients, spontaneous clearance of HCV seems to be associated with the two genotypes GC-CA of (-137and-607) IL-18 polymorphism and the AA genotype of ApoI /Fas gene.
- Pawlotsky JP: Virus de l’hépatite C et réponse immunitaire. Gastroenterol Clin Biol. 2001, 25: B123-B133.PubMedGoogle Scholar
- Thimme R, Bukh J, Spangenberg C, Wieland S, Pemberton J, Steiger C, Govindarajan Purcell, Chisari FV: Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc Natl Acad Sci USA. 2002, 99 (24): 15661-15668. 10.1073/pnas.202608299.PubMed CentralView ArticlePubMedGoogle Scholar
- Smith AJP, Humphries SE: Cytokine and cytokine receptor gene polymorphisms and their functionality. Cytokine & Growth Factor Reviews. 2009, 20: 43-59. 10.1016/j.cytogfr.2008.11.006.View ArticleGoogle Scholar
- Constantini PK, Syczewska MW, Clare M, Boron KA, Mc Farlane IG, Cramp ME, Donaldson PT: IL1, IL10, and TNFα gene polymorphisms in hepatitis C virus infection : an investigation of the relationships with spontaneous viral clearance and response to interferon therapy. Liver. 2002, 22 (5): 404-12. 10.1034/j.1600-0676.2002.01553.x.View ArticlePubMedGoogle Scholar
- Yin LM, Zhu WF, Wei L, Xu XY, Sun DG, Wang YB, Fan WM, Yu M, Tian XL, Wang QX, Gao Y, Zhuang H: Association of interleukin 12 p40 gene 3’ untranslated region polymorphism and outcome of HVC infection. World J Gastroenterol. 2004, 10 (16): 2330-2333.PubMed CentralView ArticlePubMedGoogle Scholar
- Choi C, Benveniste E: Fas ligand/Fas system in the brain: regulator of immune and apoptotic responses. Brain Research Reviews. 2004, 44: 65-81. 10.1016/j.brainresrev.2003.08.007.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd.